PolyCore Therapeutics
Data Collection & Internet Portals · Pennsylvania, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3180 Chestnut St Ste 104, Philadelphia, ...Phone Number
(215) 206-2754Website
www.polycoretherapeutics.comRevenue
<$5 MillionIndustry
About PolyCore Therapeutics
Is PolyCore Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if PolyCore Therapeutics is spiking on competitors!
Funding: Get notified immidiatlly once PolyCore Therapeutics has new funding data
Product Launch: Get notified when PolyCore Therapeutics launches new products
Earning: See what the market has to say on PolyCore Therapeutics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at PolyCore Therapeutics
Check if PolyCore Therapeutics has recently received funding, and reach out quickly before it becomes old news!
PolyCore Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if PolyCore Therapeutics had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at PolyCore Therapeutics
Find 2 more new buyers
Compare Similar Companies to PolyCore Therapeutics
Compare insights from companies similar to PolyCore Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
PolyCore Therapeutics
Company Profile Activity
Activity Insights
PolyCore Therapeutics is experiencing very low activity levels compared to other companies in the Media & Internet sector.
What does this means?
PolyCore Therapeutics is drawing exceptional interest within the Media & Internet industry, suggesting notable developments or strong market momentum, learn more about PolyCore Therapeutics.
PolyCore Therapeutics financials insights
Gather financial insights about PolyCore Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Private Equity
$4.7M
PolyCore Therapeutics Tech Stack
A closer look at the technologies used by PolyCore Therapeutics
PolyCore Therapeutics News & Media
PolyCore Therapeutics Secures Seed Financing to Address Motor Symptoms and Dyskinesia Associated with Parkinson’s Disease
PHILADELPHIA--(BUSINESS WIRE)--PolyCore Therapeutics, Inc., a biopharmaceutical company developing treatments for patients suffering from dyskinesia and cognitive impairment associated with neurodegenerative disorders, today announced a seed investment from Xontogeny, LLC and Ben Franklin Technology Partners of Southeastern Pennsylvania to advance their lead compound, PCT-3012, a novel G protein-biased D3 receptor agonist to reduce motor impairment in Parkinson’s Disease, through IND-enabling w
Top Data Collection & Internet Portals Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding PolyCore Therapeutics
HugeDomains specializes in the sale of premium domain names, offering a wide selection of domains for various purposes. They provide affordable payment options, including interest-free plans, and guarantee quick delivery of purchased domains. Their services are aimed at individuals and businesses looking to secure a unique online presence. With a c... Read More